AMN Healthcare Services (NYSE:AMN – Get Free Report) and Mangoceuticals (NASDAQ:MGRX – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.
Risk and Volatility
AMN Healthcare Services has a beta of 0.42, meaning that its stock price is 58% less volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 2.15, meaning that its stock price is 115% more volatile than the S&P 500.
Insider & Institutional Ownership
99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 16.0% of Mangoceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Earnings & Valuation
This table compares AMN Healthcare Services and Mangoceuticals”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| AMN Healthcare Services | $2.73 billion | 0.66 | -$95.70 million | $2.68 | 17.47 |
| Mangoceuticals | $460,000.00 | 8.96 | -$20.64 million | ($1.01) | -0.19 |
Mangoceuticals has lower revenue, but higher earnings than AMN Healthcare Services. Mangoceuticals is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for AMN Healthcare Services and Mangoceuticals, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| AMN Healthcare Services | 0 | 4 | 4 | 0 | 2.50 |
| Mangoceuticals | 1 | 0 | 0 | 0 | 1.00 |
AMN Healthcare Services presently has a consensus target price of $36.50, suggesting a potential downside of 22.06%. Given AMN Healthcare Services’ stronger consensus rating and higher probable upside, equities research analysts clearly believe AMN Healthcare Services is more favorable than Mangoceuticals.
Profitability
This table compares AMN Healthcare Services and Mangoceuticals’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| AMN Healthcare Services | 3.06% | 19.92% | 5.93% |
| Mangoceuticals | -4,794.60% | -96.39% | -89.60% |
Summary
AMN Healthcare Services beats Mangoceuticals on 10 of the 14 factors compared between the two stocks.
About AMN Healthcare Services
AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions. The Physician and Leadership Solutions segment provides locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. The Technology and Workforce Solutions segment offers language services, vendor management systems, workforce optimization, and outsourced solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists. It offers its services under the brands, including AMN Healthcare, Nursefinders, HealthSource Global Staffing, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is headquartered in Dallas, Texas.
About Mangoceuticals
Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
Receive News & Ratings for AMN Healthcare Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMN Healthcare Services and related companies with MarketBeat.com's FREE daily email newsletter.
